Humphreys K, Weingardt K R
Psychiatr Serv. 2000 Dec;51(12):1568-9. doi: 10.1176/appi.ps.51.12.1568.
Managed health care systems often use treatment readmission data as an indicator of psychiatric patient outcome and program performance. This study of 3,018 inpatients being treated for substance abuse in Department of Veterans Affairs medical centers found that across a range of measures and patient subpopulations, patient outcomes and program performance were virtually independent of treatment readmission. These findings suggest that even though readmission for substance abuse treatment may have value as an easily obtainable measure of health care utilization and cost, it cannot serve as a valid substitute for direct assessment of patient outcome or program performance.
管理式医疗保健系统通常将治疗再入院数据用作精神科患者治疗结果和项目绩效的指标。这项对退伍军人事务部医疗中心3018名接受药物滥用治疗的住院患者的研究发现，在一系列衡量标准和患者亚群体中，患者治疗结果和项目绩效实际上与治疗再入院情况无关。这些发现表明，尽管药物滥用治疗的再入院情况作为一种易于获得的医疗保健利用和成本衡量标准可能有价值，但它不能作为直接评估患者治疗结果或项目绩效的有效替代指标。
